It is simple, the cure is the goal, we don’t just cover symptoms.
At GrittGene Therapeutics, our Mission is to cure patients with Myotonic Dystrophy Type 2. We develop the cure of tomorrow by combining all the tools available today. With our disease-centric approach, with the cure being the main driving force, GrittGene’s interdisciplinary platform is free from the constraints of big pharma. In our hands, alleviation of disease symptoms is just an observable effect of the cure. The collaborative environment at GrittGene combines the power of expert scientists from various branches of pharmaceutical industries and more. We employ cutting-edge technologies including CRISPR and Artificial Intelligence for tissue-specific delivery and gene-specific editing, a combination of small-molecule treatment with biologicals and gene therapy. We are not limited by internal technology; we are free to develop treatment the right way through collaboration and a combination of the complete pool of technologies and wealth of knowledge at our disposal today.
With our capacity to use a wide range of expertise and experiences in diverse aspects of drug discovery and beyond, w e believe that the effective use of all possible tools will lead us to success.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 801 N Brand Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://grittgene.com/
- Keywords
- London.
- HQ
- Glendale, California
Grittgene Therapeutics Questions
Grittgene Therapeutics's website is http://grittgene.com/
Grittgene Therapeutics's LinkedIn profile is https://www.linkedin.com/company/grittgene-therapeutics
Grittgene Therapeutics has
10 employees.
View email and phone details for 10
employees at Grittgene Therapeutics.
Grittgene Therapeutics's industry is
Biotechnology Research
Grittgene Therapeutics's top competitors are
Clinsoft Llc,
Aip Scientific,
Anzo Bio,
Statecs,
Modicus Prime,
Paspigioni,
Atlant Clinical,
Armat Analytics,
Proone Labs,
Biobrain Pro.
Grittgene Therapeutics's categories are Biotechnology Research
Grittgene Therapeutics's founding year is 2022
